Innovation Pharmaceuticals Inc.
IPIXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$155504
P/E Ratio—
52W High$0.05
52W Low$0.00001
Innovation Pharmaceuticals Inc.（IPIX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IPIX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2023-06 | 2022-06 | 2021-06 | 2020-06 | 2019-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | ($0.00B) | $0.00B | ($0.00B) |
| Gross Margin %(computed) | — | 100.00% | — | 100.00% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| Operating Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.01 | $-0.04 | $-0.03 | $-0.05 |
| Wtd Avg Shares | 0.51B | 0.50B | 0.39B | 0.24B | 0.18B |
| EBITDA | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Innovation Pharmaceuticals Inc.
关于Innovation Pharmaceuticals Inc.（IPIX）损益表
Innovation Pharmaceuticals Inc.（IPIX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年，IPIX实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.00B)（净利率—）。
常见问题
IPIX · 4 问Innovation Pharmaceuticals Inc.（IPIX）2023财年营收为$0.00B，同比down100.0%。
IPIX revenueIPIX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09